08.45 The impact of biologic therapies on t cell subsets in rheumatoid arthritis and ankylosing spon...
08.45 The impact of biologic therapies on t cell subsets in rheumatoid arthritis and ankylosing spondylitis: a long term follow-up study
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
BackgroundRheumatoid arthritis (RA) and ankylosing spondylitis (AS) are both characterised by alterations within T-cell subsets. Studies on the impact of biologic therapies, especially of IL6-receptor-antagonists (IL6ra) on this phenotype are limited. We aimed to characterise the T cell repertoire of patients on long-standing biologic treatment and...
Alternative Titles
Full title
08.45 The impact of biologic therapies on t cell subsets in rheumatoid arthritis and ankylosing spondylitis: a long term follow-up study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1873689403
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1873689403
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2016-211055.45
